期刊文献+

干扰素栓剂治疗宫颈人乳头状瘤病毒感染临床分析 被引量:10

Clinical analysis of interferon suppository in treatment of cervical human papillomavirus infection
原文传递
导出
摘要 目的探讨干扰素栓剂治疗宫颈人乳头状瘤病毒(HPV)感染的临床价值,为临床选择术式提供参考。方法选择2013年1月-2014年1月80例宫颈病变实施宫颈电热圈环切术(LEEP)手术患者,所有患者术前检测均有高危HPV感染,按照患者自愿原则分为对照组与观察组,各40例,观察组在手术治疗的基础上联合使用干扰素栓剂治疗,对比两组患者治疗有效率、HPV转阴率、症状评分等指标。结果观察组治疗有效率为95.00%,明显高于对照组80.00%,对比差异有统计学意义(χ2=4.114,P<0.05);观察组转阴率为85.00%,明显高于对照组65.00%,对比差异均有统计学意义(χ2=4.267,P<0.05);观察组治疗后临床症状体征积分、中医证候评分分别为3.57±0.57、3.42±0.94,改善均优于对照组,对比差异有统计学意义(P<0.05);观察组平均创面愈合时间为(4.51±1.01)周,明显短于对照组,对比差异有统计学意义(t=5.847,P<0.05)。结论干扰素栓剂治疗宫颈人乳头状瘤病毒感染临床效果好,利于改善临床症状,值得临床推广应用。 OBJECTIVE To explore the clinical value of interferon suppository in treatment of cervical human papillomavirus infection(HPV)so as to provide guidance for selection of surgery mode.METHODS A total of 80 patients with cervical lesions who underwent the cervical loop electrosurgical excision procedure(LEEP)in the hospital from Jan 2013 to Jan 2014 were enrolled in the study,and all the enrolled patients were detected to have the high-risk HPV infections before the surgery.The patients were divided into the control group and the observation group according to the principle of voluntary,with 40 cases in each.The observation group was treated with surgical procedure combined with interferon suppository.The effective rate of treatment,negative rate of HPV,and symptom score were observed and compared between the two groups of patients.RESULTS The effective rate of treatment of the observation group was 95.00%,significantly higher than 80.00% of the control group(χ2=4.114,P〈0.05).The negative rate of the observation group was 85.00%,significantly higher than 65.00% of the control group(χ2=4.267,P〈0.05).The clinical symptom score and TCM syndrome score of the observation group were respectively 3.57±0.57 and 3.42±0.94 after the treatment,significantly better than those of the control group(P〈0.05).The average wound healing time of the observation group was(4.51±1.01)weeks,significantly shorter than that of the control group(t=5.847,P〈0.05).CONCLUSIONThe interferon suppository can achieve significant clinical effect on treatment of the cervical human papillomavirus infection and is conducive to the improvement of clinical symptoms,and it is worthy to be promoted in the hospital.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2016年第1期164-166,共3页 Chinese Journal of Nosocomiology
基金 浙江省卫生厅基金资助项目项目(2013KYB213)
关键词 干扰素 人乳头状瘤病毒 感染 宫颈电热圈环切术 Interferon Human papillomavirus Infection Cervical loop electrosurgical excision procedure
  • 相关文献

参考文献3

二级参考文献62

  • 1李季,曹文苓,颜景兰,黎小东,关艳冰,田广南.宫颈糜烂患者HPVs潜伏感染研究[J].中国临床医学,2005,12(1):127-128. 被引量:5
  • 2Correa P. A human model of gastric carcinogenesis. Cancer Res 1988; 48: 3554-3560.
  • 3Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yama- guchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789.
  • 4Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gas- tric carcinoma in Mongolian gerbils. Cancer Res 1998; 58: 4255-4259.
  • 5Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helico- bacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998; 115: 642-648.
  • 6Mutoh H, Sakurai S, Satoh K, Tamada K, Kita H, Osawa H, Tomiyama T, Sato Y, Yamamoto H, Isoda N, Yoshida T, Ido K, Sugano K. Development of gastric carcinoma from intes- tinal metaplasia in Cdx2-transgenic mice. Cancer Res 2004; 64: 7740-7747.
  • 7Marshall LF, Becker DP, Bowers SA, Cayard C, Eisenberg H, Gross CR, Grossman RG, Jane JA, Kunitz SC, Rimel R, Tabaddor K, Warren J. The National Traumatic Coma Data Bank. Part 1: Design, purpose, goals, and results. J Neuro- surg 1983; 59: 276-284.
  • 8Atherton JC, Blaser MJ. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest 2009; 119: 2475-2487.
  • 9Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Im- munologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various auto- immune diseases. J Immunol 1995; 155: 1151-1164.
  • 10Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD, Isaacs JD, Lechler RI. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood 2001; 98: 2736-2744.

共引文献95

同被引文献125

  • 1钱德英.宫颈锥切术的适应证及并发症[J].中国实用妇科与产科杂志,2004,20(7):401-402. 被引量:141
  • 2陶萍萍,卞美璐,李敏,刘军.HPV多重感染与宫颈病变关系探讨[J].中国妇产科临床杂志,2006,7(2):94-96. 被引量:112
  • 3吴欧江.CO_2激光联合磷甲酸钠对复发性尖锐湿疣患者血清Th1/Th2细胞因子的影响[J].现代医药卫生,2007,23(18):2752-2752. 被引量:4
  • 4Kjaer SK,Van den Brule AJ,Bock JE,et al. Human papil- lomavirus-The most significant risk determinant of cervi- cal intraepithelial neoplasia[J]. Int J Cancer, 1996,65 (5) : 601-606.
  • 5Walboomers JM,Jacobs MV,Manos MM,et al. Human pa- pillomavirus is a necessary cause of invasive cervical cancer worldwide[J]. J Pathol, 1999,189(1) : 12-19.
  • 6Bae JH,Kim C J, Park TC,et al. Persistence of human pa- pillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure[J]. Int J Gynecol Cancer, 2007,17(6) : 1271-1277.
  • 7Kreimer AR, Katki HA, Schiffman M, et al. Viral determi- nants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical in traepithelial neoplasia grade 2 or 3[J]. Cancer Epidemiol Biomarkers Prey, 2007,16( 1 ) : 11-16.
  • 8Mlynarczyk BB,Majewska A, Malejczyk M, et al. Antivi- ral medication in sexually transmitted diseases. Part l: HSV, HPV[J]. Mini Rev Med Chem, 2013,13 ( 13 ) : 1837.
  • 9Laurence Gerard,Dominique Salmon-Ceronb. Pharma- cology and clinical use of foscamet[J]. International Jour- nal of Antimicrobial, 1995,5 (4) : 209-217.
  • 10Peter M, Stransky N, Couturier J,et al. Frequent genomic- structural alterations at HPV insertion sites in cervical carcinoma[J]. J Patho 1,2010,221 (3) : 320.

引证文献10

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部